The in vitro analysis of B cells of MS patients showed the activation of cell survival and proliferation (mitogen-activated protein kinase (MAPK)), and proinflammatory (signal transducer and activator of transcription [STAT]) pathways [127]. Here, WNK2 is linked to myeloid sarcoma.